QT Vascular said it acquired a new technology platform created by an undisclosed developer in Israel called Java that it plans to develop as an aortic valvuloplasty balloon for transcatheter aortic valve implants.
TransMedics heart preservation system used in Aussie transplants
Transmedics said surgeons in Australia used its organ care system to preserve and assess a trio of hearts from donors whose organs had stopped beating, before the hearts were successfully transplanted.
Globus Medical snaps up allograft maker Transplant Technologies
ReFlow has new Wingman35 in U.S. market
Stealth hypertension startup Sympara Medical raises nearly $6m
Gynesonics wins FDA nod for VizAblate pilot trial
Gynesonics said it won an FDA investigational device exemption for its VizAblate system with an outpatient option for treating symptomatic uterine fibroids.
Life Spine creates Centric Medical ankle & foot unit
Life Spine launched a new division called Centric Medical, after receiving FDA marketing clearance for its Tarsa-Link system for internal bone fixation of fractures, fusions, and osteotomies in the foot and ankle.
Survey: Stroke still a mystery to many
Sorin drops $20m on stake in Respicardia
Sorin Group (BIT:SRN) said it invested $20 million in a minority stake and controlling option in Minnetonka, Minn.-based Respicardia, which is developing implantable devices to treat central sleep apnea.
Sensory Medical raises $1.4m for Relaxis restless legs treatment
Sensory Medical shook a leg on a 2nd tranche of funding since receiving FDA clearance last spring for its device to relieve symptoms of restless legs syndrome, reporting $1.4 million in fresh funding on the heels of a $1 million tranche in June.
Medrobotics taps backers for $20m
Medrobotics said it closed on $20 million in new funding in a preferred stock sale to prior backers as plans to expand its commercial footprint in Europe.
Raynham, Mass.-based Medrobotics also said that it’s "met all applicable FDA requirements" to distribute its Flex Retractor in the U.S.